Streetbeat News

Equity Actions

ZBH

Analyst ratings for Zimmer Biomet Holdings (NYSE:ZBH) have shown a diverse range from bullish to bearish over the last three months, with recent actions including both upgrades and downgrades. The average 12-month price target for ZBH has increased to $135.0, reflecting a 3.39% rise from the previous target. Zimmer Biomet, a leader in orthopedic reconstructive implants, has shown a revenue growth of 6.3% as of December 31, 2023, but its ROE is below industry standards. Despite this, its net margin and ROA outperform industry averages, and its debt-to-equity ratio is below the industry average, indicating strong financial health.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 6:01 pm

HPP

Recent analyst ratings for Hudson Pacific Properties (NYSE:HPP) show a mix of somewhat bullish and indifferent sentiments, with 4 somewhat bullish and 3 indifferent ratings. The average 12-month price target is now $7.7, a 16.03% decrease from the previous $9.17 target. Analysts from firms like Piper Sandler and Morgan Stanley have adjusted their price targets and ratings, reflecting concerns over the company's financial performance, including a significant revenue decline of -17.23% and challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 6:00 pm

AAPL

Apple Inc (NASDAQ:AAPL) reported Q2 financial results surpassing Street estimates, leading to positive analyst reactions. The company announced updated guidance, an increased dividend, and a $110 billion buyback. Analysts highlighted the potential of artificial intelligence (AI) to drive an upgrade cycle, especially within iPhone sales, and noted Apple's strong performance in China and its services segment. Opinions on Apple's AI strategy and its impact on future product cycles varied among analysts.

Portfolio Pulse from Chris Katje

May 03, 2024 | 5:37 pm

ABNB

AMZN

BABA

CAVA

CVNA

HOG

KSS

TJX

TSLA

Today's session highlighted significant whale activity in the options market for 10 consumer discretionary stocks, indicating potential trading opportunities. The activity involved both bullish and bearish sentiments across various expiration dates and strike prices for companies like TSLA, TJX, HOG, BABA, CVNA, CAVA, ABNB, KSS, AMZN, and FL. This options activity could suggest market expectations and investor strategies regarding these stocks.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 5:35 pm

AAPL

AMD

BILL

ENPH

FROG

NET

NVDA

PLTR

SEMR

SPT

Today's session highlighted significant whale activity in the options market for 10 Information Technology stocks, indicating potential trading opportunities. Notable movements include bearish call option sweeps for NVDA, AMD, PLTR, and ENPH, a bullish call sweep for AAPL, bearish put trades for FROG, SPT, and BILL, and bullish put sweeps for NET and SEMR. These activities suggest varied investor sentiment across these stocks, with significant trades made in anticipation of future price movements.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 5:35 pm

ANIX

Anixa Biosciences' 13D SEC filing reveals that President, COO & CFO Michael Catelani now holds a 5.25% stake in the company as of April 30, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 5:34 pm

BXP

Boston Properties (NYSE:BXP) has seen a 7.85% increase in its short percent of float since the last report, with 8.06 million shares sold short, representing 7.01% of available shares. It would take about 5.81 days to cover these short positions based on current trading volume. This rise in short interest indicates a more bearish market sentiment towards BXP, although it has less short interest compared to its peer group average of 8.87%. The increase in short interest can be seen as a potential bullish signal for the stock.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 5:30 pm

OLMA

Olema Pharmaceuticals (OLMA) saw significant activity in its October 18 $15 call options, with 156 contracts traded at $1.9 each against an open interest of 1547 contracts. This activity comes ahead of the company's estimated earnings release on May 14, after the market closes. The stock reference price at the time of the option activity was $10.78.

Portfolio Pulse from Charles Gross

May 03, 2024 | 5:19 pm

ARES

Ares Management (NYSE:ARES) received diverse analyst ratings over the last three months, with a total of 8 ratings ranging from bullish to indifferent. The average 12-month price target for ARES has been raised to $145.88, marking a 6.29% increase from the previous target of $137.25. Analyst actions included both upgrades and downgrades, with price targets adjusted accordingly. Ares Management's financial performance shows strong revenue growth and ROE, but challenges in net margin, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 5:00 pm

AAPL

AEON

OMI

SGBX

SPT

TNDM

UPLD

Nasdaq surged 2% with Apple posting upbeat Q2 results, announcing a $110-billion stock buyback and a dividend increase. Information technology shares led gains, while energy shares fell. Safe & Green Holdings, Upland Software, and Tandem Diabetes Care saw significant stock increases after positive financial results. Conversely, AEON Biopharma, Sprout Social, and Owens & Minor experienced substantial declines following disappointing outcomes.

Portfolio Pulse from Avi Kapoor

May 03, 2024 | 4:49 pm